Inflammation generates various changes in body iron homeostasis, including iron sequestration in the reticuloendothelial system with ensuing hypoferremia and anemia of chronic disease. Increased iron accumulation is caused by hepcidin-mediated down-regulation of the iron export protein ferroportin and higher iron uptake. However, enhanced iron acquisition by macrophages cannot be accounted for by the previously reported transferrin receptor (TfR1) down-regulation in macrophages exposed to lipopolysaccharide (LPS)/interferon ␥ (IFN␥) because it impairs a major iron uptake mechanism. Because TfR1 is up-regulated by the hypoxia-inducible factor (HIF-1), we investigated the effect of inflammatory and anti-inflammatory signals on HIF-1-mediated TfR1 gene expression. Inflammatory states are associated with changes in body iron homeostasis (1). The main systemic response is a rapid fall in plasma iron concentration accompanied by iron sequestration in the reticuloendothelial system. By restricting iron availability for erythroid progenitor cells, prolonged hypoferremia may limit hemoglobin synthesis and cause inflammation-related anemia (2, 3). Increased iron retention within inflammatory macrophages, which is favored by the induction of the iron storage protein ferritin (4 -8) and regarded as a host attempt to withhold iron from the invading pathogens (1, 9, 10), may be due to increased iron uptake and decreased iron export (9). Characterization of the interaction between the acute phase protein hepcidin and the iron exporter ferroportin has shed light on the molecular mechanisms underlying the blockade of macrophage iron release (2, 3, 11). The cytokine-triggered increase in circulating hepcidin causes the internalization and degradation of ferroportin (12), the major iron exporter, thus blocking iron release from macrophages (13). However, although it has been shown that direct exposure to a bolus of hepcidin rapidly lowers serum iron (14) and that peak urinary hepcidin levels in LPS-treated subjects precede the development of hypoferremia (15), the rapid onset of hypoferremia in LPS-treated mice (16 -19) suggests that factors other than hepcidin-dependent ferroportin down-regulation (e.g. iron uptake) may be important for iron sequestration within reticuloendothelial cells during the very early phase of the inflammatory response.The pathways of iron acquisition by macrophages are less clear, as are the changes induced by inflammatory stimuli. This is particularly true in the case of the role of changes in the internalization of transferrin-bound iron through the transferrin receptor (TfR1) 2 during the development of reticuloendothelial iron sequestration under inflammatory conditions. A number of studies have shown that exposure to inflammatory stimuli for 10 -24 h down-regulates TfR1 expression (5, 6, 20 -23) and, because this impairs a major iron uptake mechanism (21, 23), it cannot account for the increased accumulation of iron in macrophages. This inhibition of TfR1 expression is post-transcriptionally control...